GENE EXPRESSION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Gene Expression Market Size and Forecast – 2025 to 2032

The global gene expression market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to 2032. This growth is driven by increasing investments in genomics research, advancements in sequencing technologies, and the rising demand for personalized medicine, which collectively enhance the adoption of gene expression analysis in clinical and research settings worldwide.

Key Takeaways of the Global Gene Expression Market

• In 2025, instruments (PCR systems, next-generation sequencing systems, microarray scanners, etc.) are projected to account for the largest share of the gene expression market at 48.1%.
• Among applications, the drug discovery and development segment is expected to dominate with a 45.6% share in 2025, reflecting the growing use of gene expression technologies in therapeutic research.
• By technology, DNA microarray is expected to lead the market with a 32. 4% share in 2025, supported by its proven reliability and widespread adoption in genomics studies.
• North America is expected to lead the market, holding a share of 39.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with an estimated market share of 23.4% in 2025.

Market Overview

A significant market trend is the integration of artificial intelligence and machine learning with gene expression data analytics, improving the accuracy and speed of data interpretation. Additionally, expanding applications in cancer diagnostics and drug discovery, along with growing awareness about the potential of gene expression profiling in predicting disease progression, are shaping the market landscape. These trends are expected to propel innovation and adoption rates, fueling sustained market expansion over the forecast period.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Gene Expression Market Insights, By Product Type – Leading Edge Technologies are Fueling Growth in the Instruments of Global Gene Expression Market

By product type, instruments (PCR systems, next-generation sequencing systems, microarray scanners, etc.) is expected to hold the highest share of the gene expression market with 48.1% in 2025 due to its critical contribution to the precise and high-throughput analysis of genes. This powerful market place stance is being driven by the fact that there is constant introduction of innovative technologies and the need to have automated, sensitive, and accurate instruments that can meet the varied research requirements.

In October 2024, 10x Genomics, a leading biotechnology company specializing in single-cell and spatial biology instruments, launched its new Chromium GEM-X Flex and GEM-X Universal Multiplex products to make single-cell and gene expression analysis more accessible and affordable. The advanced instruments enhance performance, scalability, and cost efficiency, enabling researchers to perform high-throughput experiments more effectively and at lower costs.

Gene Expression Market Insights, By Application – Drug Discovery and Development as the Primary Application is Driving the Gene Expression Market

Drug discovery and development is one of the segments that will account the largest share with 45.6% in 2025, due to the high demand for innovative therapeutics and personalized treatment strategies. Gene expression is part and parcel of the drug development process, starting with identification and validation of the target in the beginning and biomarker discovery and safety evaluation at the end.

These technologies have proven to be very important to the pharmaceutical companies as they seek to decipher the molecular pathways that are involved in diseases and thus discovering targeted therapies that are more effective and have less adverse effects.

Gene Expression Market Insights, By Technology – DNA Microarray Plays a Pioneering Role in Technological Adoption within Gene Expression Analysis

Based on technology, DNA microarray conquers the market with an estimated share of 32.4% in 2025 because of its developed utility, flexibility, and cost-effective high-throughput. Since its inception, DNA microarrays have been the basis of a vast array of parallel gene expression profiling studies involving a relative ease of analyzing thousands of genes in parallel.

The highly advanced protocols, data processing pipelines and comprehensive base of application of this technology have assisted in its continued popularity and has particularly been utilized in mass studies of gene expression variation across populations or conditions.

Role of Artificial Intelligence (AI) in the Global Gene Expression Market

• AI is redefining the global gene expression market by enhancing efficiency, reducing costs, and enabling large-scale data-driven insights. Its integration allows automation of complex experimental workflows such as high-throughput sequencing, gene quantification, and real-time PCR analysis minimizing human error and improving reproducibility.
• Predictive analytics powered by AI models assists in identifying gene expression signatures associated with diseases, drug responses, and biomarkers, allowing faster hypothesis testing and precision diagnostics. Platforms, such as Deep Genomics and BenevolentAI, further demonstrate how AI enables personalized medicine by correlating genomic expression data with patient-specific phenotypes for tailored therapeutic development.
• Beyond efficiency, AI is creating new opportunities from genomic data services to next-generation diagnostics while scaling operations through automation and cloud platforms. Though challenges like data privacy and model transparency remain, AI’s power to uncover hidden genetic patterns and guide faster discoveries positions it as a key enabler of precision medicine and long-term market growth.

Regional Insights

To learn more about this report, Download Free Sample

North America Gene Expression Market Analysis and Trends

North America dominates the global gene expression market, accounting for an estimated 39.3% of the market share in 2025, primarily due to its robust ecosystem comprising advanced research infrastructure, substantial government funding, and the strong presence of leading industry players. There is a strong presence of major companies such as Thermo Fisher scientific, Illumina Inc, and Bio-Rad laboratories that are continuously improving on their product portfolios by incorporating innovative solutions to gene expression analysis.

In June 2024, Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics, launched the ddSEQ Single-Cell 3’ RNA-Seq Kit along with its Omnition v1.1 Analysis Software to enhance single-cell gene expression research. The new kit, used with Bio-Rad’s ddSEQ Cell Isolator, enables efficient and affordable single-cell RNA sequencing and gene expression analysis across fields like oncology, immunology, and neurology.

Asia Pacific Gene Expression Market Analysis and Trends

Asia Pacific is projected to have the fastest market growth share of 23.4% in 2025, because of the growing state efforts to strengthen the biotechnology research, the rising healthcare spending, and the growing pharmaceutical and biotech market. The new economies like China, India, Japan and South Korea are making huge investments in genomics and molecular diagnostics in order to facilitate precision medicine and drug discovery processes.

The region enjoys increasing number of talented researchers and the development of sophisticated gene expression technologies with the aid of governmental initiatives such as Precision Medicine Initiative in China and Biohealth Industry Strategy in South Korea.

Global Gene Expression Market Outlook for Key Countries

U.S. Gene Expression Market Analysis and Trends

The U.S. is still a dominant in the gene expression market with its robust biopharmaceutical sector and state-of-the-art research centers. The largest vendors, including Thermo Fisher Scientific and Illumina, are innovators, and they provide high-tech sequencing and gene expression analysis systems which are used to conduct research and clinical diagnostics. Government agencies have focused on precision medicine and genomics research that provides a sufficient market growth potential.

In October 2025, Gene Matrix, a U.S.-based biotechnology company specializing in AI-powered genomics and precision medicine, announced the expansion of its Fulton Labs facility to advance gene expression and genetic testing capabilities across the U.S.

Germany Gene Expression Market Analysis and Trends

The German market in gene expression has the advantage of developed healthcare facilities and high investment in the life sciences research. European giants such as QIAGEN based in Germany make significant contributions of innovative gene expression kits and automation platforms. The regulatory environment in the country promotes biotech innovation and public-private collaboration in the area of personalized medicine and oncology research that extensively depends on the information on gene expression to discover biomarkers.

In August 2025, the University Medical Centre Göttingen, a leading German research hospital, announced its participation in a major European project to develop a new gene therapy for heart failure aimed at restoring normal electrical conduction in weakened heart muscles.

China Gene Expression Market Analysis and Trends

The fast-growing gene expression market in China is led by the huge government investment in genomics and biotechnology, such as the ones supporting precision medicine and cancer research. The country has large local companies such as BGI Group, which provides full-service gene sequencing and expression and a strategic partnership with other countries across the world. Increased biotech startup and the development of better regulatory frameworks can help accelerate the utilization of gene expression technologies in research and clinical practice.

On October 01, 2025, the International Consortium for Primate Brain Mapping led by China’s Institute of Neuroscience launched a 25-year global effort to create multiomic maps of marmoset, macaque, and human brains, including single-cell gene expression atlases and connectomes, with partners across two dozen countries to accelerate insights into neurological disease and cognition.

India Gene Expression Market Analysis and Trends

The market of gene expression in India is growing at a fast pace due to the increased investments in the field of biotechnology, increased molecular diagnostic labs, and government promotion of precision medicine. The accessibility of gene expression tools is growing due to collaborations between domestic and international biotech companies, and their growing popularity in cancer and infectious disease diagnoses makes the markets stronger.

In March 2025, Bharat Biotech International Limited, a leading Indian company known for its pioneering vaccine innovations, launched the country’s first vertically integrated Cell and Gene Therapy and Viral Production Facility at Genome Valley in Hyderabad, India. The new 50,000-square-foot center expands Bharat Biotech’s capabilities beyond vaccines into advanced regenerative and personalized therapies focused on targeted gene expression, immune modulation, and long-term cell survival.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In October 2025, Takara Bio Inc., a leading biotechnology company specializing in single-cell and genomic research solutions, launched its expanded Trekker Single-Cell Spatial Mapping Kits to include compatibility with formalin-fixed, paraffin-embedded samples. This upgrade marks a major step in spatial biology, allowing researchers to perform high-sensitivity, single-cell gene expression analysis using archived tissue samples.
• In August 2025, researchers evaluated AlphaGenome, the advanced AI model developed by DeepMind to predict gene expression from DNA sequences, and found it significantly improved the accuracy of personal gene expression prediction compared to earlier models like Enformer. Using GTEx data, AlphaGenome achieved an odds ratio of 3.0 in predicting expression direction and corrected several previous inconsistencies in sequence-expression correlations.
• In June 2025, DeepMind, an artificial intelligence research company of Google known for its breakthroughs in protein structure prediction, introduced AlphaGenome, a new AI model designed to predict gene expression and regulation directly from DNA sequences. The model represents a major step toward understanding how genetic variations influence biological functions and disease development, with potential applications in drug discovery and therapeutic design.
• In April 2025, the Wellcome Sanger Institute, a world-leading genomics research center in the U.K., announced a major collaboration with Pacific Biosciences, a U.S.-based innovator in long-read sequencing technology, to map how gene expression shapes the human immune system.

Top Strategies Followed by Global Gene Expression Market Players

• Established market leaders, which are usually multinational companies, are highly oriented on research and development (R&D) in order to innovate and produce high-performance products that can meet the changing needs of researchers and clinical uses. Such companies have invested heavily in the design of highly advanced gene expression platforms, reagents and software that increase accuracy, throughput and user-friendliness.
  • In April 2025, AGC Biologics, a global contract development and manufacturing organization specializing in biopharmaceuticals, launched its new Cell and Gene Technologies Division to strengthen capabilities in cell and gene therapy production and support developers worldwide.

• The key strategy that is frequently pursued by mid-level companies in the gene expression market is to focus on price-sensitive customers by balancing cost and quality. These players are focusing on creating affordable solutions that do not compromise on the acceptable quality of performance but are cheaper than the high-end products of the leading players in the market.
  • Examples of mid-level companies in the gene expression market include Bio-Techne Corporation, Promega Corporation, and Fluidigm Corporation, which focus on offering high-quality yet cost-efficient instruments, reagents, and assay solutions that cater to academic institutions and smaller biotech firms.

• Small and new companies or those that specialize tend to find their niche in the market of gene expression are targeting niche markets and new customized products. Their nimbleness allows them to quickly pick up on the latest technologies, including microfluidics, data analysis based on artificial intelligence, or new assay chemistries, in contrast to larger than usual competitors.
  • For small-scale or specialized companies, examples include Parse Biosciences, Molecular Loop Biosciences, and NanoString Technologies, which emphasize niche innovations such as single-cell gene expression profiling, spatial transcriptomics, and targeted RNA sequencing.

Market Report Scope

Gene Expression Market Report Coverage

Gene Expression Market Dynamics

To learn more about this report, Download Free Sample

Gene Expression Market Driver - Growing Demand for Targeted Therapeutics and Biomarkers

The rising focus on individual medicine has greatly contributed to the need to have targeted therapeutics and biomarkers, which is a powerful driving force in the worldwide market of gene expression. The recent developments in the fields of molecular biology and genomics have helped the researcher and the pharmaceutical corporations to gain a better insight into the genetic pathology of various diseases and this has led to the creation of specific therapeutic product to match the genetic profile. This is a highly accurate method of reducing the negative impacts and enhancing the treatment effect and the gene expression analysis has become an invaluable tool in the discovery of new biomarkers and treatment targets.

In June 2025, Mission Bio, a leading life sciences company specializing in single-cell DNA and multiomics analysis, launched its Single-Cell Genotype and Targeted Gene Expression assay as part of the Tapestri Platform to advance cancer drug development. The new solution enables simultaneous genotype and targeted gene expression profiling from over 10,000 single cells, offering deeper insights into tumor heterogeneity and therapeutic resistance.

Gene Expression Market Opportunity - Integration of AI and Bioinformatics in Gene Expression Analysis

The adoption of artificial intelligence (AI) and novel bioinformatics solutions into the gene expression analysis is a promising expansion opportunity in the global market of gene expression. With the ever growing volume and complexity of the genomic data, the traditional formats of analysis are struggling to process and interpret large volumes of data effectively. AI-based algorithms and machine learning models increase the accuracy and speed of detection of complex patterns, gene expression patterns, and regulatory processes.

In December 2024, QIAGEN, a global leader in molecular diagnostics and life sciences, introduced its AI-based Ingenuity Pathway Analysis (IPA) Interpret tool to streamline the interpretation of complex biological and gene expression data. The new solution uses artificial intelligence combined with QIAGEN’s extensive curated database to help researchers quickly identify key genes, biological pathways, and molecular interactions, improving understanding of processes such as disease mechanisms and ligase enzyme activity.

Analyst Opinion (Expert Opinion)

• Gene expression market is growing rapidly, owing to the technological developments in the next-generation sequencing, RNA-Sequence, and real-time PCR which enhances accuracy and scalability in genetic studies. Increasing government and pharmaceutical investments, and efforts such as the All of Us Program by National Institutes of Health and Horizon Europe by the EU are catalyzing the work of genomic research and collaboration. The opportunities are increasing with the introduction of AI-based genomics, cloud computing, and multi-omics integration despite high equipment prices and the difficulty of data analysis.
• Weaknesses: From the latest events in the world, such as the ASHG Annual Meeting, ESHG Congress, and AGBT Conference, the world has become innovative and has adopted the policy discussion. The technology has been taken up by industry leaders including Illumina and Thermo Fisher who are creating faster and cost effective analysis systems, and national genomics initiatives in the U.K., Japan, and the U.S. are ongoing with increased clinical uptake of gene expression, cementing its application in modern precision medicine.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
  • Consumables and Reagents (Kits, Assays and Probes, DNA Chips etc.)
  • Software and Services
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Drug Discovery and Development
  • Clinical Diagnostics
  • Research and Development
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • DNA Microarray
  • PCR-Based (qPCR, RT-PCR)
  • RNA Sequencing (RNA-Seq)
  • Northern Blotting
  • Next-Generation Sequencing (NGS)
  • Serial Analysis of Gene Expression (SAGE)
• Workflow Stage Insights (Revenue, USD Bn, 2020 - 2032)
  • Sample Collection and Preparation
  • RNA Isolation and Purification
  • cDNA Synthesis and Amplification
  • Detection and Quantification
  • Data Analysis and Interpretation
• Sample Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Human Samples
  • Animal Samples
  • Microbial Samples
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals and Clinical Laboratories
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc
  • Illumina Inc
  • QIAGEN N.V
  • Bio-Rad Laboratories Inc
  • Roche Diagnostics
  • PerkinElmer Inc
  • Takara Bio Inc
  • Promega Corporation
  • GE Healthcare
  • Pacific Biosciences of California Inc
  • Oxford Nanopore Technologies
  • Fluidigm Corporation
  • Lonza Group Ltd
  • Eurofins Genomics

Sources

Primary Research Interviews

Industry Stakeholders List

• Biotechnology Company Executives
• Laboratory Equipment Manufacturers
• Genomics Platform Providers
• Academic Research Heads
• CRO and Diagnostic Lab Managers
• Technology Innovation Officers

End Users List

• Clinical Geneticists
• Molecular Biologists
• Pharmacogenomics Researchers
• Pathologists
• Bioinformatics Scientists
• Hospital Laboratory Directors

Government and International Databases

• National Institutes of Health (NIH)
• European Medicines Agency (EMA)
• U.S. Food and Drug Administration (FDA)
• World Health Organization (WHO)
• Centers for Disease Control and Prevention (CDC)
• European Commission Research & Innovation Portal

Trade Publications

• Genetic Engineering & Biotechnology News (GEN)
• BioTechniques
• Laboratory Equipment Magazine
• Nature Biotechnology Industry Reports
• Pharmaceutical Technology
• The Scientist

Academic Journals

• Nature Genetics
• PLOS Genetics
• Nucleic Acids Research
• Genome Research
• BMC Genomics
• Frontiers in Genetics

Reputable Newspapers

• The New York Times – Science Section
• The Guardian – Health & Science
• Financial Times – Life Sciences Coverage
• The Washington Post – Health
• The Wall Street Journal – Health & Tech
• Reuters Health

Industry Associations

• American Society of Human Genetics (ASHG)
• European Society of Human Genetics (ESHG)
• International Society for Computational Biology (ISCB)
• Biotechnology Innovation Organization (BIO)
• Global Alliance for Genomics and Health (GA4GH)
• Human Genome Organization (HUGO)

Public Domain Resources

• GenBank (NCBI)
• EMBL-EBI Database
• Gene Ontology Consortium
• Human Protein Atlas

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years